DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹2,191 Cr | ₹1,600 Cr | ₹1,824 Cr | ₹2,960 Cr | ₹1,984 Cr |
What is the latest Profit After Tax of DIVIS LABORATORIES ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹2,191 Cr |
| Mar2024 | ₹1,600 Cr |
| Mar2023 | ₹1,824 Cr |
| Mar2022 | ₹2,960 Cr |
| Mar2021 | ₹1,984 Cr |
How is Profit After Tax of DIVIS LABORATORIES Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,191 Cr | 36.94 | |
| Mar2024 | ₹1,600 Cr | -12.28 | |
| Mar2023 | ₹1,824 Cr | -38.39 | |
| Mar2022 | ₹2,960 Cr | 49.19 | |
| Mar2021 | ₹1,984 Cr | - | |
Compare Profit After Tax of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹182,138.3 Cr | 1.5% | 9.1% | 9.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹453,750.0 Cr | 0.6% | 13.6% | 8.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,314.0 Cr | 1.5% | 8.2% | 35.7% | Stock Analytics | |
| CIPLA | ₹113,225.0 Cr | -2.1% | 13.7% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,037.0 Cr | -1.4% | 8% | 7.4% | Stock Analytics | |
| MANKIND PHARMA | ₹103,845.0 Cr | 0.4% | 14.5% | 0.6% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 1.5% |
9.1% |
9.7% |
| SENSEX | -0.3% |
-4.3% |
-8.9% |
You may also like the below Video Courses